Drug factory · FDA FEI 1000359047
Baxter R and D Europe
Boulevard d Angleterre 2-4, Braine l Alleud, Belgium
Problems found, fixed voluntarily at FDA's last inspection, Feb 2, 2023.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
2 drug inspections on record since 2013: 0 with no problems, 2 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Olive Oil and Soybean Oil | Tests it | Baxter Healthcare Corporation | 0338-9540 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Feb 2, 2023 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Jun 21, 2013 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
Registered with FDA for: analysis.